罗德岛州人乳头瘤病毒疫苗入学要求与经提供者验证的接种率变化
本研究利用2011-2017年美国青少年免疫调查数据,采用双重差分法评估罗德岛州2015年实施的人乳头瘤病毒疫苗入学要求对13岁前经提供者验证接种率的影响。结果显示,与其它州男孩相比,罗德岛男孩接种概率增加14个百分点(β=0.139, 95%CI=0.073,0.205),女孩无显著差异。
要点
- 罗德岛HPV疫苗入学要求使男孩13岁前接种概率提高14个百分点。
- 女孩中未观察到类似接种率提升。
- 入学要求可能是提升全国HPV疫苗接种率的可行选项。
核心结论
- 罗德岛州HPV疫苗入学要求提高了男孩的疫苗接种率,对女孩无显著影响。
研究设计与样本
- 基于2011-2017年全国青少年免疫调查的横断面数据,分析样本限定为有提供者验证HPV疫苗接种报告的参与者(n=145,153)。
- 采用双重差分法评估2015年罗德岛州实施的HPV疫苗入学要求。
主要发现
- 与其它州男孩相比,罗德岛男孩13岁前接种HPV疫苗的概率增加14个百分点(β=0.139, 95%CI=0.073,0.205)。
- 罗德岛女孩与其它州女孩相比,接种概率无显著差异(β=0.009, 95%CI=-0.068,0.086)。
临床怎么用
- 可考虑将学校入学要求作为提升青少年HPV疫苗接种率的公共卫生策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Human papillomavirus vaccine school entry requirements may be an opportunity to improve the low rates of human papillomavirus vaccination among adolescents. This study evaluates changes in provider-verified human papillomavirus vaccine uptake by age 13 years for adolescents in Rhode Island compared with all other states from 2011 to 2017. METHODS: The National Immunization Survey-Teen 2011-2017, a population-based cross-sectional survey, was analyzed in 2019. The survey included telephone interviews and provider-verified reports of vaccination among U.S. adolescents aged 13-17 years. The sample was subset to participants with provider-verified human papillomavirus vaccination reports (n=145,153). A difference-in-differences approach evaluated the Rhode Island human papillomavirus vaccination school entry requirement enacted in 2015. The main outcome was provider-verified human papillomavirus vaccine uptake by age 13 years. RESULTS: Compared with boys in other states, boys in Rhode Island had an increase of 14 percentage points in the probability of uptake of human papillomavirus vaccination by age 13 years (β=0.139, 95% CI=0.073, 0.205). No such differences were observed on comparing girls in Rhode Island with girls in other states (β=0.009, 95% CI= -0.068, 0.086). CONCLUSIONS: The Rhode Island school entry requirement for human papillomavirus vaccination improved rates of vaccine uptake among boys and may be a useful option for improving human papillomavirus vaccination nationally.
引用
- Thompson EL, Livingston MD, Daley EM, et al. Rhode Island Human Papillomavirus Vaccine School Entry Requirement Using Provider-Verified Report. Am J Prev Med. 2020. PMID: 32430223. doi:10.1016/j.amepre.2020.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。